Literature DB >> 22301502

Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases.

Jason T Lewis1, Andre M Oliveira, Antonio G Nascimento, David Schembri-Wismayer, Eric A Moore, Kerry D Olsen, Joaquin G Garcia, Melissa L Lonzo, Jean E Lewis.   

Abstract

Sarcomas of the sinonasal region are rare. We describe a distinct spindle cell sarcoma of the sinonasal region characterized by concomitant neural and myogenic differentiation. Consultation files and surgical cases from Mayo Clinic were reviewed. Twenty-eight cases were identified that met the inclusion criteria. Clinical data were collected from medical records, consultation letters, and referring pathologists. Reverse transcriptase-polymerase chain reaction for synovial sarcoma fusion transcripts was performed on 18 cases. Cytogenetic studies were performed on 2 cases. The 21 female and 7 male patients ranged in age from 24 to 85 years (mean, 52 y). All cases showed a characteristic histology, which included a cellular spindle cell neoplasm with uniform, elongate nuclei and an infiltrative growth pattern. All tumors demonstrated expression of S-100 with actin positivity in 96% of cases tested. Reverse transcriptase-polymerase chain reaction for synovial sarcoma fusion transcripts was negative in all cases tested. Cytogenetic studies conducted on 2 cases demonstrated the chromosomal translocation t(2;4). The nasal cavity (54%) and ethmoid sinus (57%) were the most commonly involved areas, singly or in combination. Follow-up information was available for 57% (16/28) of cases, with a mean of 8.3 years. Of these, 44% (7/16) experienced at least 1 recurrence. No patient has developed metastases or died of disease. We describe a unique tumor with a characteristic morphologic, immunophenotypic, and cytogenetic profile. On the basis of the locally aggressive nature of this lesion we believe it is best considered a low-grade sarcoma and suggest the term low-grade sinonasal sarcoma with neural and myogenic features.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301502     DOI: 10.1097/PAS.0b013e3182426886

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  35 in total

1.  Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.

Authors:  Shih-Chiang Huang; Ronald A Ghossein; Justin A Bishop; Lei Zhang; Tse-Ching Chen; Hsuan-Ying Huang; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

2.  Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas.

Authors:  Katja Specht; Lei Zhang; Yun-Shao Sung; Marisa Nucci; Sarah Dry; Sumathi Vaiyapuri; Gunther H S Richter; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

3.  Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.

Authors:  Markku Miettinen; Peter A McCue; Maarit Sarlomo-Rikala; Wojciech Biernat; Piotr Czapiewski; Janusz Kopczynski; Lester D Thompson; Jerzy Lasota; Zengfeng Wang; John F Fetsch
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

4.  Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.

Authors:  Xiaoke Wang; Krista L Bledsoe; Rondell P Graham; Yan W Asmann; David S Viswanatha; Jean E Lewis; Jason T Lewis; Margaret M Chou; Michael J Yaszemski; Jin Jen; Jennifer J Westendorf; André M Oliveira
Journal:  Nat Genet       Date:  2014-05-25       Impact factor: 38.330

Review 5.  Angioleiomyoma of the Sinonasal Tract: Analysis of 16 Cases and Review of the Literature.

Authors:  Abbas Agaimy; Michael Michal; Lester D R Thompson; Michal Michal
Journal:  Head Neck Pathol       Date:  2015-06-06

6.  What Is New in the World Health Organization 2017 Histopathology Classification?

Authors:  Adel K El-Naggar
Journal:  Curr Treat Options Oncol       Date:  2017-07

Review 7.  Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.

Authors:  Simon Andreasen; Justin A Bishop; Henrik Hellquist; Jennifer Hunt; Katalin Kiss; Alessandra Rinaldo; Alena Skálová; Stefan M Willems; Michelle Williams; Alfio Ferlito
Journal:  Virchows Arch       Date:  2018-08-14       Impact factor: 4.064

Review 8.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

Review 9.  Imaging Review of New and Emerging Sinonasal Tumors and Tumor-Like Entities from the Fourth Edition of the World Health Organization Classification of Head and Neck Tumors.

Authors:  K E Dean; D Shatzkes; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-14       Impact factor: 3.825

Review 10.  [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].

Authors:  A Agaimy; F Haller; A Hartmann
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.